G. C. CRAWLEY - Concepedia

Author

G. C. CRAWLEY

AstraZeneca (United Kingdom)

Also Known As

G C Crawley, G. C. CRAWLEY, G. C. Crawley, G.C. Crawley, Graham C. Crawley

Publications

346

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)East Cheshire NHS Trust

About

G. C. CRAWLEY is an author at AstraZeneca (United Kingdom) specializing in natural sciences, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	6	6	197
2	Biochemistry	6	6	197
3	Engineering	3	3	75
4	Medicine	3	3	118
5	Biomolecular Engineering	2	2	55

G. C. CRAWLEY

Publications

314

Citations

H-Index

Page 1

	Year	Citations
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors G. C. CRAWLEY, Robert I. Dowell, Philip N. Edwards, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyNew SeriesPharmaceutical ChemistryDrug Resistance	1992	84
(Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity Bird, G. C. CRAWLEY, Martin P. Edwards, Journal of Medicinal Chemistry	1991	52
Pre‐clinical pharmacology of ICI D2138, a potent orally‐active non‐redox inhibitor of 5‐lipoxygenase R. M. McMillan, K E Spruce, G. C. CRAWLEY, British Journal of Pharmacology	1992	45
Microbial Modification of Mycophenolic Acid D. F. Jones, R. H. Moore, G. C. CRAWLEY Journal of the Chemical Society C Organic PolyphenolicsBiosynthesisBioorganic ChemistryEngineeringBiochemistry	1970	35
Total synthesis of (±)-fluorocurarine, the racemate of a Calabash-curare alkaloid G. C. CRAWLEY, John Harley-Mason Journal of the Chemical Society D Chemical Communications J. Harley-masonG. C. CrawleyPhysicsBiochemistryNatural Sciences	1971	24
Chiral Dioxolane Inhibitors of Leukotriene Biosynthesis: Structure-Activity Relationships and Syntheses Using Asymmetric Dihydroxylation G. C. CRAWLEY, Malcolm T. Briggs Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryMedicinal ChemistryBiosynthesisLeukotriene Biosynthesis	1995	20
Asymmetric Syntheses of (S)-2-Methyl-3,4,5,6-tetrahydro-2H-pyran-4- one and (2S,6S)-2,6-trans-Dimethyl-3,4,5,6-tetrahydro-2H-pyran-4-one Which Employ a Common Lactol Intermediate G. C. CRAWLEY, Malcolm T. Briggs The Journal of Organic Chemistry Asymmetric SynthesesEngineeringBiochemistryDonut IconNatural Sciences	1995	20
Stereoselectivity in the anionic oxy-Cope rearrangement of acyclic vinyl sulfides Andrew Woodland, G. C. CRAWLEY, Richard C. Hartley Tetrahedron Letters Chemical EngineeringEngineeringAcyclic Vinyl SulfidesOrganic ChemistryCatalysis	2003	20
4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity G. C. CRAWLEY, Malcolm T. Briggs, Robert I. Dowell, Journal of Medicinal Chemistry Pharmaceutical ScienceQuantitative PharmacologyAltmetric Attention ScoreChemical BiologyPharmaceutical Chemistry	1993	14

Page 1